JP3615802B2 - Antibacterial monomers and their synthesis - Google Patents
Antibacterial monomers and their synthesis Download PDFInfo
- Publication number
- JP3615802B2 JP3615802B2 JP27136194A JP27136194A JP3615802B2 JP 3615802 B2 JP3615802 B2 JP 3615802B2 JP 27136194 A JP27136194 A JP 27136194A JP 27136194 A JP27136194 A JP 27136194A JP 3615802 B2 JP3615802 B2 JP 3615802B2
- Authority
- JP
- Japan
- Prior art keywords
- boric acid
- meth
- methacryloylamino
- acid
- acryloylaminophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dental Preparations (AREA)
Description
【0001】
【産業上の利用分野】
本発明は、抗菌性を有し、且つ、(メタ)アクリル酸やこれらのエステル等と共重合可能なモノマーともなり得る抗菌性モノマーに関する。
【0002】
【従来の技術】
硼酸塩、例えば硼酸ナトリウムは、従来から防腐剤、静菌剤、創傷洗浄剤、うがい薬(口腔洗浄剤)等として用いられてきた。
【0003】
又、硼酸は、多価アルコール、特にシス位に2つの水酸基を有するアルコールとエステル型錯イオンを形成して弱い殺菌作用を示すことが知られている。
【0004】
【発明の解決しようとする課題】
従って、硼酸化合物、例えば上に示した硼酸と多価アルコールから形成されるエステル型錯イオンの塩を、(メタ)アクリル酸エステル等の混合物からなる歯科用接着剤や充填剤に混合して、これらの歯科用接着剤や充填剤に抗菌性を付与することが考えられる。
【0005】
しかし、殺菌剤や静菌剤として用い得る硼酸化合物の多くは室温で固体なので、歯科用接着剤や充填剤と均一に混合することが困難である。又、歯科用接着剤や充填剤は、口腔内という常に湿潤な環境で用いられるので、硼酸塩や硼酸と多価アルコールのエステル型錯イオンは、硬化後の接着剤や充填剤から容易に溶け出してしまい、抗菌効果が長続きしないという問題があった。
【0006】
本発明は、(メタ)アクリル酸やこれらのエステル等と共重合可能な抗菌性モノマーを提供することにより、上記の問題を解決することを目的とする。
【0007】
【課題解決のための手段】
本発明の抗菌性モノマーは、下記の式(I)
【0008】
【化2】
【0009】
(R1 は−H又は−CH3 を表わす)
で示される構造を有する(メタ)アクリロイルアミノフェニル硼酸を主要な成分とするものである。
【0010】
このような(メタ)アクリロイルアミノフェニル硼酸としては、2−(メタクリロイルアミノ)フェニル硼酸、3−(メタクリロイルアミノ)フェニル硼酸、及び4−(メタクリロイルアミノ)フェニル硼酸、2−(アクリロイルアミノ)フェニル硼酸、3−(アクリロイルアミノ)フェニル硼酸、及び4−(アクリロイルアミノ)フェニル硼酸がある。
【0011】
これらの(メタ)アクリロイルアミノフェニル硼酸は、例えば、2−、3−、又は4−アミノフェニル硼酸と(メタ)アクリル酸クロリドとの反応によって得られる。この反応を下の式(II)に示す。
【0012】
【化3】
【0013】
(R1 は−H又は−CH3 を表わす)
【0014】
【発明の効果】
本発明の(メタ)アクリロイルアミノフェニル硼酸は、グラム陰性菌、グラム陽性菌のいずれに対しても抗菌性を有し、且つ、歯科用接着剤や充填剤の主成分である(メタ)アクリル酸やこれらのエステル等と通常のラジカル重合により共重合可能である。従って、本発明の(メタ)アクリロイルアミノフェニル硼酸を添加することにより、歯科用接着剤や充填剤に半永久的に抗菌性を付与することができる。
【0015】
【実施例】
以下、本発明について実施例を用いて具体的に説明する。
【0016】
[実施例1]
3−(メタクリロイルアミノ)フェニル硼酸の合成
滴下漏斗及びコンデンサーを備えた二口フラスコ(200ml)に、3−アミノフェニル硼酸(1.86g、0.01mol)と水61mlを入れ、良く撹拌した後、炭酸水素ナトリウム(5.0g、0.06mol)を少量づつ加えた。次に滴下漏斗よりメタクリル酸クロリド(1.2ml、0.0123mol)を一滴づつ室温で約15分で加えた。撹拌を十分に行いながら反応を更に3時間行うと全体が白濁してきた。
【0017】
反応終了後、ガラスフィルターで生成物を濾別し、乾燥した。収量は1.4gであった。濾液を濃塩酸で酸性にし、24時間静置すると、結晶0.3gが得られた。生成物1.4gを沸騰水30mlに溶かし、濾過により不溶分を除いた。濾液に濃塩酸10mlを加えて酸性にすると、白色の3−(メタクリロイルアミノ)フェニル硼酸の針状結晶1.2gが得られた。得られた結晶について、元素分析、赤外線吸収スペクトル測定及び1 H−NMR測定を行った。結果は以下の通りであった。
【0018】
元素分析
実測値(C10H13BNO3 として):
C,58.59wt% ; H,5.90wt% ; N,6.83wt%
計算値:C,58.58wt% ; H,6.06wt% ; N,6.87wt%
赤外線吸収スペクトル
(株式会社日立製作所製、I−5020FT−IR使用、KBr法で測定)
ν 3310−3420cm−1(NH,OH),1658cm−1(C=O),1624cm−1(C=C)
1 H−NMRスペクトル(株式会社日立製作所製、I−240使用、測定周波数60MHz、測定溶媒はCDCl3 +DMSO−d6 使用)
α−CH3 =2.0ppm(s,3H),CH2 =5.4ppm,5.85ppm(d,2H),phenyl=7.22−7.88ppm(tt,d,d,s,4H),9.4ppm(s,1H).
尚、赤外線吸収スペクトル及び1 H−NMRスペクトルについては各々図1及び図2に示す。
【0019】
得られた3−(メタクリロイルアミノ)フェニル硼酸について、次に抗菌性を調べた。抗菌性の測定には濾紙法を用いた。
【0020】
先ず、予め培養した3種類の細菌、Streptococcus mutans、Lactobacillus casei 及びActinomyses viscosusを各々寒天に加えて、この寒天を固まらせた。次いで、これらの寒天の各々に、3−(メタクリロイルアミノ)フェニル硼酸の5%又は10%DMSO溶液を染み込ませた直径6mmの濾紙を置き、37℃で12時間培養し、細菌発育阻止帯の幅を測定した。対照群として、DMSOのみを用いた場合についても、同様にして測定した。結果を表1に示す。
【0021】
【表1】
【0022】
表1の結果から、DMSOのみを用いた場合に比べ、3−(メタクリロイルアミノ)フェニル硼酸の5%あるいは10%DMSO溶液を用いた場合のほうが、上記3種の細菌のいずれに対しても細菌発育阻止帯が広くなっていた。
【0023】
このことから、3−(メタクリロイルアミノ)フェニル硼酸が上記3種の細菌に対し抗菌性を有することが判る。
【図面の簡単な説明】
【図1】実施例1で得られた3−(メタクリロイルアミノ)フェニル硼酸の赤外線吸収スペクトル。
【図2】実施例1で得られた3−(メタクリロイルアミノ)フェニル硼酸の60MHz 1H−NMRスペクトル。[0001]
[Industrial application fields]
The present invention relates to an antibacterial monomer that has antibacterial properties and can also be a monomer copolymerizable with (meth) acrylic acid or an ester thereof.
[0002]
[Prior art]
Borate salts such as sodium borate have been conventionally used as antiseptics, bacteriostatic agents, wound cleansing agents, gargles (oral cleansing agents) and the like.
[0003]
In addition, boric acid is known to form an ester-type complex ion with a polyhydric alcohol, particularly an alcohol having two hydroxyl groups in the cis position, and exhibits a weak bactericidal action.
[0004]
[Problem to be Solved by the Invention]
Therefore, a boric acid compound, for example, a salt of an ester type complex ion formed from boric acid and a polyhydric alcohol shown above is mixed with a dental adhesive or filler made of a mixture of (meth) acrylic acid ester, It is conceivable to impart antibacterial properties to these dental adhesives and fillers.
[0005]
However, since many of the boric acid compounds that can be used as bactericides and bacteriostatic agents are solid at room temperature, it is difficult to uniformly mix them with dental adhesives and fillers. In addition, since dental adhesives and fillers are used in a constantly moist environment in the oral cavity, borate and ester complex ions of boric acid and polyhydric alcohol are easily dissolved from the cured adhesives and fillers. There was a problem that the antibacterial effect did not last long.
[0006]
An object of the present invention is to solve the above-mentioned problems by providing an antibacterial monomer copolymerizable with (meth) acrylic acid or an ester thereof.
[0007]
[Means for solving problems]
The antibacterial monomer of the present invention has the following formula (I)
[0008]
[Chemical 2]
[0009]
(R 1 represents —H or —CH 3 )
The main component is (meth) acryloylaminophenyl boric acid having a structure represented by:
[0010]
As such (meth) acryloylaminophenyl boric acid, 2- (methacryloylamino) phenyl boric acid, 3- (methacryloylamino) phenyl boric acid, 4- (methacryloylamino) phenyl boric acid, 2- (acryloylamino) phenyl boric acid, There are 3- (acryloylamino) phenyl boric acid and 4- (acryloylamino) phenyl boric acid.
[0011]
These (meth) acryloylaminophenyl boric acids are obtained, for example, by reacting 2-, 3-, or 4-aminophenyl boric acid with (meth) acrylic acid chloride. This reaction is shown below in formula (II).
[0012]
[Chemical 3]
[0013]
(R 1 represents —H or —CH 3 )
[0014]
【The invention's effect】
The (meth) acryloylaminophenyl boric acid of the present invention has antibacterial properties against both gram-negative bacteria and gram-positive bacteria, and (meth) acrylic acid is a main component of dental adhesives and fillers And these esters can be copolymerized by ordinary radical polymerization. Therefore, by adding the (meth) acryloylaminophenyl boric acid of the present invention, antibacterial properties can be imparted semi-permanently to dental adhesives and fillers.
[0015]
【Example】
Hereinafter, the present invention will be specifically described with reference to examples.
[0016]
[Example 1]
Synthesis of 3- (methacryloylamino) phenyl boric acid In a two-necked flask (200 ml) equipped with a dropping funnel and a condenser, 3-aminophenyl boric acid (1.86 g, 0.01 mol) and 61 ml of water were placed and stirred well. Sodium bicarbonate (5.0 g, 0.06 mol) was added in small portions. Next, methacrylic acid chloride (1.2 ml, 0.0123 mol) was added dropwise from the dropping funnel at room temperature in about 15 minutes. When the reaction was further carried out for 3 hours with sufficient stirring, the whole became cloudy.
[0017]
After completion of the reaction, the product was filtered off with a glass filter and dried. The yield was 1.4g. The filtrate was acidified with concentrated hydrochloric acid and allowed to stand for 24 hours to obtain 0.3 g of crystals. 1.4 g of the product was dissolved in 30 ml of boiling water, and the insoluble matter was removed by filtration. When the filtrate was acidified with 10 ml of concentrated hydrochloric acid, 1.2 g of white 3- (methacryloylamino) phenylboric acid needle crystals were obtained. Elemental analysis, infrared absorption spectrum measurement, and 1 H-NMR measurement were performed on the obtained crystals. The results were as follows.
[0018]
Elemental analysis measured values (as C 10 H 13 BNO 3 ):
C, 58.59 wt%; H, 5.90 wt%; N, 6.83 wt%
Calculated value: C, 58.58 wt%; H, 6.06 wt%; N, 6.87 wt%
Infrared absorption spectrum (manufactured by Hitachi, Ltd., using I-5020FT-IR, measured by KBr method)
ν 3310-3420 cm −1 (NH, OH), 1658 cm −1 (C═O), 1624 cm −1 (C═C)
1 H-NMR spectrum (manufactured by Hitachi, Ltd., using I-240, measuring frequency 60 MHz, measuring solvent using CDCl 3 + DMSO-d 6 )
α-CH 3 = 2.0 ppm (s, 3H), CH 2 = 5.4 ppm, 5.85 ppm (d, 2H), phenyl = 7.22-7.88 ppm (tt, d, d, s, 4H) , 9.4 ppm (s, 1 H).
The infrared absorption spectrum and 1 H-NMR spectrum are shown in FIGS. 1 and 2, respectively.
[0019]
The obtained 3- (methacryloylamino) phenyl boric acid was then examined for antibacterial properties. The filter paper method was used for the measurement of antibacterial properties.
[0020]
First, three types of bacteria previously cultured, Streptococcus mutans, Lactobacillus casei, and Actinomyces viscosus were each added to agar to solidify the agar. Next, a filter paper having a diameter of 6 mm soaked with 5% or 10% DMSO solution of 3- (methacryloylamino) phenyl boric acid was placed on each of these agars and cultured at 37 ° C. for 12 hours. Was measured. As a control group, the same measurement was performed when only DMSO was used. The results are shown in Table 1.
[0021]
[Table 1]
[0022]
From the results shown in Table 1, it was found that the use of a 5% or 10% DMSO solution of 3- (methacryloylamino) phenylboric acid compared to the case of using only DMSO against the above three types of bacteria. The stunt zone was wide.
[0023]
This shows that 3- (methacryloylamino) phenyl boric acid has antibacterial properties against the above three types of bacteria.
[Brief description of the drawings]
1 is an infrared absorption spectrum of 3- (methacryloylamino) phenyl boric acid obtained in Example 1. FIG.
2 is a 60 MHz 1 H-NMR spectrum of 3- (methacryloylamino) phenyl boric acid obtained in Example 1. FIG.
Claims (3)
で示される構造を有する(メタ)アクリロイルアミノフェニル硼酸からなる歯科用抗菌剤。Formula (I):
A dental antibacterial agent comprising (meth) acryloylaminophenyl boric acid having a structure represented by:
で示される構造を有する(メタ)アクリロイルアミノフェニル硼酸と(メタ)アクリル酸もしくはそのエステルとの混合物または共重合体である歯科用材料。Formula (I):
A dental material which is a mixture or copolymer of (meth) acryloylaminophenyl boric acid and (meth) acrylic acid or an ester thereof having a structure represented by:
で示される構造を有する(メタ)アクリロイルアミノフェニル硼酸と(メタ)アクリル酸もしくはそのエステルとを混合あるいは共重合させることを特徴とする、歯科用材料に抗菌性を付与する方法。Formula (I):
A method for imparting antibacterial properties to a dental material, comprising mixing or copolymerizing (meth) acryloylaminophenyl boric acid having a structure represented by the formula (meth) acrylic acid or an ester thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27136194A JP3615802B2 (en) | 1994-11-04 | 1994-11-04 | Antibacterial monomers and their synthesis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27136194A JP3615802B2 (en) | 1994-11-04 | 1994-11-04 | Antibacterial monomers and their synthesis |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH08134077A JPH08134077A (en) | 1996-05-28 |
JP3615802B2 true JP3615802B2 (en) | 2005-02-02 |
Family
ID=17499006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP27136194A Expired - Fee Related JP3615802B2 (en) | 1994-11-04 | 1994-11-04 | Antibacterial monomers and their synthesis |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3615802B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2030603B1 (en) * | 2007-08-29 | 2016-10-12 | Dentsply DeTrey GmbH | Dental adhesive composition |
WO2017087925A1 (en) * | 2015-11-20 | 2017-05-26 | Dentsply Sirona Inc. | Orthodontic cement compositions and methods of use thereof |
-
1994
- 1994-11-04 JP JP27136194A patent/JP3615802B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH08134077A (en) | 1996-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5113759B2 (en) | NOVEL COMPOUND, PROCESS FOR PRODUCING THE SAME AND COMPOSITION CONTAINING THE SAME | |
EP2895138A1 (en) | Dental composition | |
US6063832A (en) | Method of setting a dental cement composition | |
TW200843796A (en) | Polymerizable composition containing hydrophilic monomer and dental material | |
KR101164302B1 (en) | Phosphate ester compound, metal salt thereof, dental material, and dental composition | |
CN101098673A (en) | Dental fillers and compositions including phosphate salts | |
JPS5996180A (en) | Adhesive | |
JP2002212019A (en) | Polyfunctional amide-based dental material | |
JP3615802B2 (en) | Antibacterial monomers and their synthesis | |
JP2010229054A (en) | New organosilicon compound, and composition comprising the same | |
JPH08104664A (en) | New(meta)acrylate monomer and denture base composition containing the same | |
US5639840A (en) | Fluoride ion releasing dental materials | |
EP1148060A1 (en) | Hydrolysis-stable and polymerisable acrylphosphonic acids | |
RU2009124485A (en) | HAIR TREATMENT COMPOSITION | |
JPS60158151A (en) | Novel amphoteric compound, disinfectant cleaning mixture containing same and manufacture of them | |
WO1997008177A1 (en) | Fumaric acid derivative and polymer thereof | |
JP3078622B2 (en) | Method of using diglycidyl phosphonate as a crosslinking agent in the production of hydrogels | |
EP2428503B1 (en) | Synthesis of tripodal catechol derivatives with a flexible base for functionalising surfaces | |
EP0471252B1 (en) | N-alkyl-N-(meth)acryloyloxyalkylcarboxamides of aromatic carboxylic acids and of aromatic carboxylic anhydrides and adhesives containing these compounds | |
WO2017064042A1 (en) | Polymerizable compositions based on thermally splittable compounds | |
JP3032155B2 (en) | Production method of betaine monomer | |
JPH0562884B2 (en) | ||
FR2443466A1 (en) | NOVEL B-LACTONS DERIVED FROM 2-HYDROXY CYCLOPENTANE CARBOXYLIC ACID, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS | |
JP2841611B2 (en) | Fluorinated surfactant | |
JP5552812B2 (en) | Monofluorophosphorylated polymer compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040810 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040915 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20041019 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20041102 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |